In 2023, the import volume of blood-grouping reagents to India stood at a lesser value than the forecasted figures for 2024 onwards. Analyzing the forecast data from 2024 to 2028 shows a steady increase in import volume, with year-to-year increments averaging around 3-4%. Specifically, the compound annual growth rate (CAGR) over this period is approximately 2.9%, indicating a consistent upward trend in import demand.
Future trends to watch for include:
- Advancements in healthcare technology which may affect reagent demand.
- Regulatory changes impacting imports.
- Market expansion driven by increased healthcare access.
